Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dupilumab ocular side effects in patients with atopic dermatitis: a systematic review
Nicoleta Neagu, Caterina Dianzani, Gianluca Avallone, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 6, pp. 820-835
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events
Faisal Fa’ak, Maryam Buni, Adewunmi Falohun, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006814-e006814
Open Access | Times Cited: 47
Real-Life Experience of Tralokinumab for the Treatment of Adult Patients with Severe Atopic Dermatitis: A Multicentric Prospective Study
Axel De Greef, Pierre‐Dominique Ghislain, Audrey Bulinckx, et al.
Clinical Drug Investigation (2023) Vol. 43, Iss. 4, pp. 299-306
Open Access | Times Cited: 23
Biologic Versus Small Molecule Therapy for Treating Moderate to Severe Atopic Dermatitis: Clinical Considerations
Sneha Butala, Leslie Castelo‐Soccio, Rishi Seshadri, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 5, pp. 1361-1373
Open Access | Times Cited: 22
Development of a Practical Guide to Implement and Monitor Diet Therapy for Eosinophilic Esophagitis
Joy W. Chang, Kara Kliewer, Emily Haller, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 7, pp. 1690-1698
Open Access | Times Cited: 18
Comparative safety of oral Janus kinase inhibitors and dupilumab in patients with atopic dermatitis: a population-based cohort study
Serena Yun‐Chen Tsai, Wanda Phipatanakul, Elena B. Hawryluk, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 5, pp. 1195-1203.e3
Closed Access | Times Cited: 8
Biologic and Small Molecule Therapy in Atopic Dermatitis
Mahek Shergill, Barinder Bajwa, Orhan Yilmaz, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1841-1841
Open Access | Times Cited: 6
S3 guideline Atopic dermatitis: Part 2 ‐ Systemic treatment
Thomas Werfel, Annice Heratizadeh, Werner Aberer, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2023) Vol. 22, Iss. 2, pp. 307-320
Open Access | Times Cited: 16
A Review of Existing and New Treatments for the Management of Hand Eczema
Jessica S. S. Ho, Sonja Molin
Journal of Cutaneous Medicine and Surgery (2023) Vol. 27, Iss. 5, pp. 493-503
Open Access | Times Cited: 14
Dupilumab‐associated ocular surface disease in atopic dermatitis patients: Clinical characteristics, ophthalmic treatment response and conjunctival goblet cell analysis
Roselie Achten, Judith L. Thijs, Marlot van der Wal, et al.
Allergy (2023) Vol. 78, Iss. 8, pp. 2266-2276
Open Access | Times Cited: 13
Association between Dupilumab and Conjunctivitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Tzu‐Yi Lin, Ching-Ya Wang, Fang‐Ying Wang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1031-1031
Open Access | Times Cited: 11
Ocular surface disease in moderate‐to‐severe atopic dermatitis patients and the effect of biological therapy
Roselie Achten, Judith L. Thijs, Marlot van der Wal, et al.
Clinical & Experimental Allergy (2024) Vol. 54, Iss. 4, pp. 241-252
Open Access | Times Cited: 4
Atopic Dermatitis (Eczema) Guidelines 2023: Highlights
Anna De Benedetto, Mark Boguniewicz, Peck Y. Ong, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 11, pp. 2955-2965
Closed Access | Times Cited: 4
Chronic Hand Eczema (CHE): A Narrative Review
G. Ghezzi, Costanza Falcidia, Giovanni Paolino, et al.
Dermatology and Therapy (2025)
Open Access
Head and neck dermatitis: a variant of atopic dermatitis
Leszek Blicharz, Agnieszka Michalczyk, Małgorzata Maj, et al.
Italian Journal of Dermatology and Venereology (2025) Vol. 160, Iss. 2
Closed Access
Ocular Adverse Events in Patients With Atopic Dermatitis Treated With Upadacitinib: A Real-Life Experience
Federica Gelato, Luca Mastorino, Pietro Quaglino, et al.
Dermatitis (2023) Vol. 34, Iss. 5, pp. 445-447
Closed Access | Times Cited: 10
Pediatric Cornea Cases
Abdelrahman M. Elhusseiny, Hajirah N. Saeed, Aisha S. Traish
Current practices in ophthalmology (2025), pp. 353-369
Closed Access
Biologics for allergy: therapeutic potential for ocular allergic diseases and adverse effects on the eye
Ken Fukuda, Tatsuma Kishimoto, Tamaki Sumi, et al.
Allergology International (2022) Vol. 72, Iss. 2, pp. 234-244
Open Access | Times Cited: 15
Tailoring Magnetite-Nanoparticle-Based Nanocarriers for Gene Delivery: Exploiting CRISPRa Potential in Reducing Conditions
David Arango, Javier Cifuentes, Paola Ruiz Puentes, et al.
Nanomaterials (2023) Vol. 13, Iss. 11, pp. 1782-1782
Open Access | Times Cited: 8
Real‐world reported adverse events related to systemic immunomodulating therapy in patients with atopic dermatitis: Results from the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry
Annelie H. Musters, Florine L van Lookeren, Lian F. van der Gang, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 38, Iss. 3, pp. 530-542
Open Access | Times Cited: 7
An Updated Reappraisal of Dupilumab in Children and Adolescents with Severe Asthma
Gian Luigi Marseglia, Amelia Licari, Maria Angela Tosca, et al.
Children (2024) Vol. 11, Iss. 7, pp. 843-843
Open Access | Times Cited: 2
An expert consensus on managing dupilumab-related ocular surface disorders in people with atopic dermatitis 2024
Michael R. Ardern‐Jones, Sara Brown, Carsten Flohr, et al.
British Journal of Dermatology (2024)
Closed Access | Times Cited: 2
Tralokinumab efficacy in a case of dupilumab‐resistant severe atopic dermatitis complicated by eczema herpeticum
Maria Efenesia Baffa, Carlo Pipitò, Francesca Montefusco, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 8
Closed Access | Times Cited: 6
Cellular mechanisms and effects of IL-4 receptor blockade in experimental conjunctivitis evoked by skin inflammation
Hongwei Han, Sheila Cummings, Kai-Ting C. Shade, et al.
JCI Insight (2023) Vol. 8, Iss. 3
Open Access | Times Cited: 5
Ocular Surface Disease in Patients With Atopic Dermatitis Treated With Dupilumab: A Prospective Case–Control Study
Paola Marolo, Simone Ribero, Paolo Caselgrandi, et al.
Cornea (2023) Vol. 43, Iss. 2, pp. 221-227
Closed Access | Times Cited: 5
Clinical trials of antibody drugs in the treatments of atopic dermatitis
Guihao Zhou, Yueyao Huang, Ming Chu
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top